BANK OF AMERICA CORP /DE/ - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 1 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$40,000
-54.0%
76,269
-33.8%
0.00%
Q2 2020$87,000
+2075.0%
115,261
+3026.1%
0.00%
Q1 2020$4,000
+33.3%
3,687
+66.5%
0.00%
Q4 2019$3,000
-83.3%
2,215
-78.0%
0.00%
Q3 2019$18,000
+63.6%
10,091
+51.7%
0.00%
Q2 2019$11,000
-83.3%
6,654
-82.0%
0.00%
Q1 2019$66,000
+450.0%
37,004
+471.4%
0.00%
Q4 2018$12,000
+200.0%
6,476
+472.1%
0.00%
Q3 2018$4,0001,1320.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders